125 related articles for article (PubMed ID: 7604141)
61. The analysis and disposition of imipramine and its active metabolites in man.
Sutfin TA; DeVane CL; Jusko WJ
Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820
[TBL] [Abstract][Full Text] [Related]
62. Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects.
Pisani F; Fazio A; Artesi C; Oteri G; Spina E; Tomson T; Perucca E
Br J Clin Pharmacol; 1992 Jul; 34(1):85-7. PubMed ID: 1352988
[TBL] [Abstract][Full Text] [Related]
63. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
Daniel W; Adamus A; Melzacka M; Szymura J; Vetulani J
Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
[TBL] [Abstract][Full Text] [Related]
64. The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.
Skjelbo E; Gram LF; Brøsen K
Br J Clin Pharmacol; 1993 Mar; 35(3):331-4. PubMed ID: 8471415
[TBL] [Abstract][Full Text] [Related]
65. Effects of recombinant drug-specific single chain antibody Fv fragment on [3H]-desipramine distribution in rats.
Shelver WL; Keyler DE; Lin G; Murtaugh MP; Flickinger MC; Ross CA; Pentel PR
Biochem Pharmacol; 1996 Feb; 51(4):531-7. PubMed ID: 8619899
[TBL] [Abstract][Full Text] [Related]
66. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers.
Shahzadi A; Javed I; Aslam B; Muhammad F; Asi MR; Ashraf MY; Zia-ur-Rahman
Pak J Pharm Sci; 2011 Jan; 24(1):63-8. PubMed ID: 21190921
[TBL] [Abstract][Full Text] [Related]
67. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
Amsterdam JD; Brunswick DJ; Potter L; Rickels K
Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927
[TBL] [Abstract][Full Text] [Related]
68. Targeting imipramine dose in children with depression.
Sallee F; Stiller R; Perel J; Rancurello M
Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
[TBL] [Abstract][Full Text] [Related]
69. A fatal intoxication involving carbamazepine, desipramine, and ethylene glycol.
Bush DM; Levine BS; Smyth DF; Caplan YH
J Anal Toxicol; 1986; 10(5):213-6. PubMed ID: 3773484
[TBL] [Abstract][Full Text] [Related]
70. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
Mahmood I; Chamberlin N
Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
[TBL] [Abstract][Full Text] [Related]
71. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
Szymura-Oleksiak J; Panas M; Chruściel W
Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
[TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetic interaction of disulfiram and antidepressants.
Ciraulo DA; Barnhill J; Boxenbaum H
Am J Psychiatry; 1985 Nov; 142(11):1373-4. PubMed ID: 4061700
[TBL] [Abstract][Full Text] [Related]
73. Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.
Sjöqvist F; Bertilsson L
Prog Clin Biol Res; 1986; 214():169-88. PubMed ID: 3523507
[TBL] [Abstract][Full Text] [Related]
74. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
Perini GI; Devinsky O; Hauser P; Gallucci WT; Theodore WH; Chrousos GP; Gold PW; Kling MA
J Clin Endocrinol Metab; 1992 Feb; 74(2):406-12. PubMed ID: 1309836
[TBL] [Abstract][Full Text] [Related]
75. Saliva carbamazepine levels in children before and during multiple dosing.
Moreland TA; Priestman DA; Rylance GW
Br J Clin Pharmacol; 1982 May; 13(5):647-51. PubMed ID: 7082531
[TBL] [Abstract][Full Text] [Related]
76. Determination of serum desipramine and 2-hydroxydesipramine for pharmacokinetic applications by HPLC with ultraviolet detection.
Kenney JT; Orsulak PJ; Kolodner RM; Burton ME
Clin Chem; 1989 Oct; 35(10):2134-6. PubMed ID: 2791284
[TBL] [Abstract][Full Text] [Related]
77. Tricyclic antidepressant-specific Fab fragments alter the distribution and elimination of desipramine in the rabbit: a model for overdose treatment.
Hursting MJ; Opheim KE; Raisys VA; Kenny MA; Metzger G
J Toxicol Clin Toxicol; 1989; 27(1-2):53-66. PubMed ID: 2769821
[TBL] [Abstract][Full Text] [Related]
78. Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure.
Cooper TB; Bark N; Simpson GM
Psychopharmacology (Berl); 1981; 74(2):115-21. PubMed ID: 6791217
[TBL] [Abstract][Full Text] [Related]
79. Desipramine and 2-hydroxy-desipramine pharmacokinetics in normal volunteers.
DeVane CL; Savett M; Jusko WJ
Eur J Clin Pharmacol; 1981 Jan; 19(1):61-4. PubMed ID: 7461025
[TBL] [Abstract][Full Text] [Related]
80. Desipramine and its 2-hydroxy metabolite in patients taking or not taking methadone.
Kosten TR; Gawin FH; Morgan C; Nelson JC; Jatlow P
Am J Psychiatry; 1990 Oct; 147(10):1379-80. PubMed ID: 2400009
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
